Boost P&K Fertilizer Output, Cut Imports: Panel

By By Rediff Money Desk, New Delhi
Dec 01, 2025 23:06
Parliamentary panel urges govt to enhance domestic P&K fertilizer production and reduce import dependence. Key recommendations inside.
New Delhi, Dec 1 (PTI) A parliamentary panel has asked the government to boost domestic production of phosphatic and potassic (P&K) fertilizers and reduce import dependence.

A Standing Committee on Chemicals and Fertilizers on Monday presented a report on self-sufficiency in the production of fertilizers with a view to curbing the import of fertilisers and reviewing constraints.

"The Committee note that the country is heavily dependent on imported raw materials for production of P&K fertilizers," it said.

The country imports nearly 95 per cent of its phosphate requirements and is 100 per cent dependent on imports of potash.

The Committee observed that any increase in global prices of these raw materials, exchange rate fluctuations and global supply chain disruptions impact the domestic cost of fertilizer production.

The report pointed out that the domestic production capacity of P&K fertilizers (which include DAP & NPK) in the country is 160 lakh tonnes per annum against the total requirement of 240 lakh tonnes per annum.

The Committee said the consumption of P&K fertilizers would increase to 305 lakh tonnes during 2035-36.

The report said that work for the commissioning of some new units and capacity enhancement initiatives is planned or is in progress in the P&K sector.

The Committee, therefore, asked the Department of Fertilizers to take steps for the timely completion of the projects already started and capacity expansion of the other existing plants.

This will enhance domestic production of P&K fertilizers and reduce dependence on imports.

In a separate report on the Department of Pharmaceutical, the Committee stressed the need to reduce the price of stent.

The panel asked the NPPA (National Pharmaceutical Pricing Authority) as well as the department to look into the matter to bring down the prices of stents.

"The Committee have also recommended that the NPPA should strictly monitor and ensure that the stents are not made available to the patients over and above the prices fixed by it and cases of overcharging, if any, may be dealt with strictly," the report said.
Source: PTI
Read More On:
p&k fertilizersfertilizer production', &#;#x27;fertilizer importsparliamentary panelnppa
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Indowind Energy Rights Issue Oversubscribed

Indowind Energy's rights issue oversubscribed by 1.04 times, raising ₹49.43 crore....

Kshema Power Bags Substation Order

Kshema Power secures order for 33 kV/220 kV AIS power substation for a 350 MW...

Alembic Pharma Gets USFDA Nod for Eye Treatment

Alembic Pharmaceuticals receives USFDA approval for generic Loteprednol Etabonate &...

Equity Mutual Funds Rebound: Rs 29,911 Cr Inflows

Equity mutual funds see a 21% rise in inflows to Rs 29,911 crore in November. AUM...

India-Canada Ties: Envoy Meets Canadian Officials

Indian envoy to Canada meets with Canadian officials to enhance bilateral ties,...

Chennai Bullion Rates Today

Opening bullion rates in Chennai on December 11th. Check gold and silver prices per...

Choppy Stock Market: Sensex, Nifty Fluctuate

Indian stock markets open positive but turn choppy amid mixed global cues. Sensex and...

Rupee Falls to 90.11 Against US Dollar

Rupee depreciates to 90.11 against US dollar amid risk-averse sentiment & high dollar...

Unilever: India Growth & GST Impact

Unilever sees huge opportunities in India due to high GDP growth and GST cuts. HUL...

Trai Recommends 6 GHz, E, V Band Allocation

Trai suggests administrative allocation of 6 GHz, E, and V bands for telecom backhaul....

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com